FDA approves AI-enabled wearable device for at-home vital sign tracking

Current Health, headquartered in Edinburgh, Scotland, has received approval from the FDA for in-home use of its wearable patient monitoring platform, previously cleared only for use in hospitals.

The Current wireless wearable, an upper arm band fitted with a smartphone-sized device, measures patients' vital signs in real time. Using proprietary artificial intelligence technology, the device can detect warning signs and potential health declines, immediately alerting both the patient and healthcare professional.

According to Current, this is the first end-to-end, real-time-tracking medical wearable and platform to be approved by the FDA. The device aims to decrease hospital readmissions and prevent avoidable disease and death.

The wearable continuously monitors a patient's respiration rate, oxygen saturation, pulse, temperature and movement, and can connect via Bluetooth with other third-party devices tracking FEV1/FVC ratio, weight, blood pressure, glucose levels and core temperature.

Current users also receive a tablet equipped with a chatbot providing medication reminders, educational information and the ability to communicate with clinicians via video or text.

More articles about AI:
AI startup streamlining electronic medical billing process receives investment from Northwestern Mutual
Member of Google's disbanded AI ethics team claims she faces retaliation for walkout
Google's AI-powered healthcare solutions require support from patients, academia, medical community

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months